AEVI GENOMIC MEDICINE
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.
AEVI GENOMIC MEDICINE
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2000-01-01
Address:
Wayne, Pennsylvania, United States
Country:
United States
Website Url:
http://www.aevigenomics.com
Total Employee:
11+
Status:
Closed
Contact:
1-610-254-4201
Email Addresses:
[email protected]
Total Funding:
78.53 M USD
Technology used in webpage:
IPv6 U.S. Server Location Microsoft
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-09-09 | neuroFix Therapeutics | neuroFix Therapeutics acquired by Aevi Genomic Medicine | 2 M USD |
Investors List
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia investment in Post-IPO Equity - Aevi Genomic Medicine
Alta Partners
Alta Partners investment in Series A - Aevi Genomic Medicine
Koor Corporate Venture Capital
Koor Corporate Venture Capital investment in Series A - Aevi Genomic Medicine
Alta Berkeley Venture Partners
Alta Berkeley Venture Partners investment in Series A - Aevi Genomic Medicine
Official Site Inspections
http://www.aevigenomics.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Aevi Genomic Medicine"
Aevi Genomic Medicine - Crunchbase Company Profile & Funding
Organization. Aevi Genomic Medicine . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Aevi Genomic Medicine focuses on translating genetic …See details»
Cerecor to Acquire Aevi Genomic Medicine - Avalo Therapeutics, Inc.
Mike Cola, Chief Executive Officer of Aevi, stated, “We at Aevi Genomics are extremely excited about joining the Cerecor organization. The combined pipeline of both organizations is an …See details»
Aevi Genomic Medicine - Craft
See insights on Aevi Genomic Medicine including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aevi Genomic Medicine, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aevi Genomic Medicine, LLC of Chesterbrook, PA. Get the latest business insights from Dun & Bradstreet.See details»
Aevi Genomic Medicine, Inc Information - RocketReach
What is the annual revenue of Aevi Genomic Medicine, Inc? The Aevi Genomic Medicine, Inc annual revenue was $188000 in 2024.See details»
Aevi Genomic Medicine, Inc - SignalHire
Organization Website: aevigenomics.com : Social Links: Phone Number: 1-610-254-4201: Aevi Genomic Medicin... industries Biotech, Pharmaceuticals: Headquarters Location: 435 Devon …See details»
Aevigenomics.com
Aevigenomics.comSee details»
Aevi Genomic Medicine (Formerly Known As Medgenics)
Aevi Genomic Medicine (Formerly Known As Medgenics) VentureRadar profile. Find out more about Aevi Genomic Medicine (Formerly Known As Medgenics), DNA, RNA and Peptide …See details»
Aevi Genomic Medicine | Company | Mindmaps
Aevi Genomic Medicine was founded as Medgenics in 2000 in Israel. Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies.See details»
Aevi Genomic Medicine - Craft
Aevi Genomic Medicine is a clinical stage biopharmaceutical company. It looks to find treatments for genetically defined diseases for which there are limited therapeutic options currently …See details»
Nextsource | Company Profile | Aevi Genomic Medicine
Explore the company profile of Aevi Genomic Medicine (aevigenomics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Aevi Genomic Medicine - M&A Summary, Ownership, and …
Www.aevigenomics.com. Profile Investors (1) M&A Activity (1) Analytics Aevi Genomic Medicine, Inc. is a biopharmaceutical company developing a technology platform for the purpose of …See details»
Aevi Genomic Medicine - Company Profile - Tracxn
Feb 25, 2025 Aevi Genomic Medicine - Therapeutics for rare diseases in areas of neurology and hematology.. Acquired by Cerecor. Raised a total funding of $28.4M over 12 rounds from 5 …See details»
Aevi Genomic Medicine - Products, Competitors, Financials, …
Aevi Genomic Medicine (NASDAQ: GNMX) is clinical stage biopharmaceutical company, researches and develops novel therapies for pediatric onset and life-altering diseases in the …See details»
Medgenics, Inc. Announces Name Change to Aevi Genomic …
PHILADELPHIA, Dec. 15, 2016 /PRNewswire/ -- Medgenics, Inc. (NASDAQ: MDGN) today announced that the company has changed its name to Aevi Genomic Medicine, Inc. Aevi …See details»
Aevi Genomic Medicine, LLC in Chesterbrook, PA - (610) 254-4201
Aevi Genomic Medicine, LLC is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Aevi Genomic Medicine - PitchBook
Jun 19, 2012 Aevi Genomic Medicine General Information Description. Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine …See details»
Cerecor to Acquire Aevi Genomic Medicine - PR Newswire
Dec 5, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. ("Aevi") (Nasdaq: GNMX) today announced that it entered into a definitive merger agreement with Cerecor, Inc....See details»
Aevi genomic medicine, inc Reviews | Read Client Reviews of Aevi ...
Aevi genomic medicine, inc Reviews Reviews 10. 4.1See details»
Aevi Genomic Medicine Enters into Worldwide License Agreement …
PHILADELPHIA, July 15, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced it has entered into an exclusive license agreement with OSI …See details»